文献速递心胸血管麻醉区域麻醉与超声疼痛医学

胸肌筋膜I和II阻滞作为微创心脏手术的补救镇痛

Pectoral Fascial (PECS) I and II Blocks as Rescue Analgesia in a Patient Undergoing Minimally Invasive Cardiac Surgery.
PubMed 文献 · Reg Anesth Pain Med · 2017-01-01

本病例报告描述一名78岁男性患者在接受微创二尖瓣修复术后出现切口剧痛且对静脉阿片类药物反应不佳,接受超声引导下右侧胸肌筋膜I和II阻滞(Pecs I和II)后获得接近完全的胸壁镇痛并改善肺力学,首次注射0.2%罗哌卡因30mL(含1:400,000肾上腺素)镇痛约24小时,随后使用266mg脂质体布比卡因混合布比卡因再次阻滞延长镇痛48小时,患者迅速脱离 supplemental oxygen。作者认为Pecs阻滞可为微创心脏手术胸廓切开术后疼痛提供重要的非阿片类镇痛选择。

要点

  • Pecs I和II阻滞可作为微创心脏手术术后切口痛的补救镇痛选择。
  • 单次注射0.2%罗哌卡因30mL提供约24小时胸壁镇痛并改善肺力学。
  • 脂质体布比卡因266mg混合布比卡因再次阻滞可延长镇痛至48小时。

核心结论

  • Pecs阻滞可为微创心脏手术胸廓切开术后患者提供有效的胸壁镇痛,并可能作为非阿片类镇痛选择。

研究设计与样本

  • 单例病例报告:一名78岁男性无慢性疼痛史,因重度二尖瓣反流经右前胸廓切开行二尖瓣修复术。

主要发现

  • 拔管后患者切口疼痛评分10/10,对静脉阿片类药物反应不佳,因疼痛导致浅呼吸和肺力学差需补充氧气并重返ICU。
  • 超声引导下右侧Pecs I和II阻滞使用0.2%罗哌卡因30mL加1:400,000肾上腺素,产生接近完全的胸壁镇痛并改善肺力学约24小时。
  • 单次阻滞消退后,使用266mg脂质体布比卡因混合布比卡因再次阻滞,额外提供48小时延长镇痛,患者迅速脱离补充氧气。

关键数值与推荐

  • Pecs I和II阻滞用药:0.2%罗哌卡因30mL加1:400,000肾上腺素;再次阻滞:266mg脂质体布比卡因混合布比卡因。
  • 首次阻滞镇痛约24小时,再次阻滞延长镇痛48小时。

临床怎么用

  • 对于微创心脏手术胸廓切开术后切口痛且对静脉阿片类药物反应不佳的患者,可考虑超声引导下Pecs I和II阻滞作为补救镇痛。
  • 可根据需要选择单次罗哌卡因阻滞或脂质体布比卡因混合布比卡因以延长镇痛时间。

局限性

  • 单例病例报告,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Patients undergoing minimally invasive cardiac surgery have the potential for significant pain from the thoracotomy site. We report the successful use of pectoral nerve block types I and II (Pecs I and II) as rescue analgesia in a patient undergoing minimally invasive mitral valve repair. CASE REPORT: In this case, a 78-year-old man, with no history of chronic pain, underwent mitral valve repair via right anterior thoracotomy for severe mitral regurgitation. After extubation, he complained of 10/10 pain at the incision site that was minimally responsive to intravenous opioids. He required supplemental oxygen because of poor pulmonary mechanics, with shallow breathing and splinting due to pain, and subsequent intensive care unit readmission. Ultrasound-guided Pecs I and II blocks were performed on the right side with 30 mL of 0.2% ropivacaine with 1:400,000 epinephrine. The blocks resulted in near-complete chest wall analgesia and improved pulmonary mechanics for approximately 24 hours. After the single-injection blocks regressed, a second set of blocks was performed with 266 mg of liposomal bupivacaine mixed with bupivacaine. This second set of blocks provided extended analgesia for an additional 48 hours. The patient was weaned rapidly from supplemental oxygen after the blocks because of improved analgesia. CONCLUSIONS: Pectoral nerve blocks have been described in the setting of breast surgery to provide chest wall analgesia. We report the first successful use of Pecs blocks to provide effective chest wall analgesia for a patient undergoing minimally invasive cardiac surgery with thoracotomy. We believe that these blocks may provide an important nonopioid option for the management of pain during recovery from minimally invasive cardiac surgery.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Yalamuri S, Klinger RY, Bullock WM, et al. Pectoral Fascial (PECS) I and II Blocks as Rescue Analgesia in a Patient Undergoing Minimally Invasive Cardiac Surgery. Reg Anesth Pain Med. 2017. PMID: 29016551. doi:10.1097/AAP.0000000000000661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。